Tag Archives: Funding

Thursday, March 28th 2019 at 5:45pm UTC NORCROSS, Ga.–(BUSINESS WIRE)– Guided Therapeutics, Inc. (Pink Sheets: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced it has successfully closed out variable rate convertible loans with three lenders and reached preliminary agreements with …

Thursday, March 28th 2019 at 11:07am UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate TRC101 (veverimer), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that …

Thursday, March 28th 2019 at 7:00am UTC Leading venture capital firm Sofinnova Partners led the Series A financing, together with New Enterprise Associates, which co-led the round BASEL, Switzerland–(BUSINESS WIRE)– Polyneuron Pharmaceuticals AG, a developer of a new class of biodegradable glycopolymers for the treatment of autoimmune diseases, today announced …

Wednesday, March 27th 2019 at 8:05pm UTC —Company delivers regulatory, scientific and commercial progress in four crops, and launches new strategy in cannabis— DAVIS, Calif.–(BUSINESS WIRE)– Arcadia Biosciences, Inc. (Nasdaq: RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today …

Wednesday, March 27th 2019 at 8:02pm UTC NEW YORK & LONDON & BERLIN–(BUSINESS WIRE)– ATAI Life Sciences, the global biotech platform dedicated to curing mental health disorders, has completed its series B financing round of $43 million (EUR 38 million). Founded in 2018 by Christian Angermayer, Lars Wilde and Florian …

Wednesday, March 27th 2019 at 8:00pm UTC NEW YORK–(BUSINESS WIRE)– Prevail Therapeutics Inc. (Prevail), a gene therapy company developing AAV-based gene therapies for patients with devastating neurodegenerative diseases, today announced it has raised $50 million in Series B financing. Proceeds of the financing will be used to advance development of …

Wednesday, March 27th 2019 at 1:00pm UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Meissa Vaccines (“Meissa”), a biotechnology company developing vaccines to prevent viral respiratory infections, announced today that it has closed a $3.4 million seed round to further develop its investigational vaccine for respiratory syncytial virus (RSV). The financing included …

Wednesday, March 27th 2019 at 1:30pm UTC $30 Million Financing Backing MIT-Developed Amphiphile Platform to Target a Wide-Range of Immunogens to the Lymph Nodes, the “Brain Center” of the Immune Response CAMBRIDGE, Mass.–(BUSINESS WIRE)– Elicio Therapeutics, a next generation immuno-oncology company, engineering therapies for cancer killing immune responses, launched today …

Wednesday, March 27th 2019 at 11:00am UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Juvenescence Ltd, a biopharmaceutical company focused on treating aging and age-related disease, is pleased to announce its latest equity investment in BYOMass Inc., a Massachusetts-based company focused on central control of metabolism in the context of aging and age-related diseases. …

Tuesday, March 26th 2019 at 4:54pm UTC National Development Council, Discover Bank, and Delaware Innovation Space Partner on Creating Jobs and Broadening Delaware’s Economic Base WILMINGTON, Del.–(BUSINESS WIRE)– Delaware Innovation Space announced today that it has received $3 million in funding from National Development Council (NDC), through a start-up innovation …